Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric readiness assessment tools in emergency care: a scoping review.

Archives of disease in childhood·2026
Same author

MAGPIE study author's reply.

Injury·2026
Same author

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

Journal of pathology informatics·2026
Same author

Finding Holes: Pathologist-Level Performance Using AI for Cribriform Morphology Detection in Prostate Cancer.

European urology open science·2026
Same author

Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations.

European urology·2026
Same author

AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors.

Cancer letters·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Jul 15, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

270

T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence.

Savannah R Duenweg1, Samuel A Bobholz2, Michael J Barrett2

  • 1Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.

Cancers
|September 28, 2023
PubMed
Summary
This summary is machine-generated.

Radiomic features from MRI scans can predict prostate cancer recurrence after surgery with high accuracy. This tool aids in screening for prostate cancer and assessing patient prognosis.

Keywords:
Gleason patternbiochemical recurrencemp-MRIprostate cancerradiomic features

More Related Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

22.5K

Related Experiment Videos

Last Updated: Jul 15, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

270
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

22.5K

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Prostate cancer (PCa) is the most common non-cutaneous cancer in men.
  • Radical prostatectomy can be curative, but biochemical recurrence (BCR) may still occur.
  • Predicting BCR and cancer presence pre-operatively is crucial for patient management.

Purpose of the Study:

  • To evaluate the ability of radiomic features from multi-parametric MRI (MP-MRI) to predict BCR.
  • To assess the utility of radiomic features in classifying prostate cancer presence.
  • To develop a radiomic tool for PCa screening and prognosis.

Main Methods:

  • Retrospective analysis of MP-MRI data from 279 patients prior to surgery.
  • Calculation of radiomic features from whole prostate and cancerous lesions.
  • Use of tree regression and classification models to predict BCR and classify cancer regions.

Main Results:

  • 10 radiomic features accurately predicted BCR with an Area Under the Curve (AUC) of 0.97.
  • Radiomic features achieved 89.9% accuracy in classifying cancer regions.
  • The study demonstrated a strong correlation between radiomic features and clinical outcomes.

Conclusions:

  • Radiomic features derived from MP-MRI show significant potential for predicting BCR in prostate cancer patients.
  • This approach can enhance the accuracy of PCa screening and prognosis assessment.
  • The findings support the development of AI-driven tools for improved prostate cancer management.